UBE2CBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.236600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.056200E-01
Normal-vs-Stage2
6.358800E-01
Normal-vs-Stage3
5.770300E-02
Normal-vs-Stage4
4.896000E-01
Stage1-vs-Stage2
1.624620E-01
Stage1-vs-Stage3
9.436500E-02
Stage1-vs-Stage4
6.872200E-01
Stage2-vs-Stage3
1.315840E-01
Stage2-vs-Stage4
6.108200E-02
Stage3-vs-Stage4
8.051700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.432000E-01
Normal-vs-AfricanAmerican
2.729600E-01
Normal-vs-Asian
5.478400E-01
Caucasian-vs-AfricanAmerican
2.795700E-02
Caucasian-vs-Asian
4.978600E-01
AfricanAmerican-vs-Asian
5.860400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.896400E-01
Normal-vs-Female
8.750600E-01
Male-vs-Female
6.634800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.360000E-01
Normal-vs-Age(41-60Yrs)
9.979000E-01
Normal-vs-Age(61-80Yrs)
6.854200E-01
Normal-vs-Age(81-100Yrs)
9.427400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.522200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.341800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.953000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.300600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.018400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.473400E-01
Normal-vs-Daily Drinker
5.243600E-01
Normal-vs-Weekly Drinker
8.167000E-01
Normal-vs-Occasional Drinker
7.880000E-01
Normal-vs-Social Drinker
7.300200E-01
Non Drinker-vs-Daily Drinker
9.632400E-01
Non Drinker-vs-Weekly Drinker
4.647400E-01
Non Drinker-vs-Occasional Drinker
1.411770E-01
Non Drinker-vs-Social Drinker
7.141400E-01
Daily Drinker-vs-Weekly Drinker
5.474600E-01
Daily Drinker-vs-Occasional Drinker
1.648650E-01
Daily Drinker-vs-Social Drinker
7.747800E-01
Weekly Drinker-vs-Occasional Drinker
4.179800E-01
Weekly Drinker-vs-Social Drinker
8.108600E-01
Occasional Drinker-vs-Social Drinker
3.179200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.889400E-01
Normal-vs-Grade 2
9.140800E-01
Normal-vs-Grade 3
8.984200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.719000E-01
Grade 1-vs-Grade 3
2.226200E-01
Grade 1-vs-Grade 4
9.889400E-01
Grade 2-vs-Grade 3
7.501400E-01
Grade 2-vs-Grade 4
9.140800E-01
Grade 3-vs-Grade 4
8.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.941000E-01
Normal-vs-NonDiabetic
7.608200E-01
Diabetic-vs-NonDiabetic
9.308200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.735800E-01
Normal-vs-NoPancreatitis
8.161800E-01
Pancreatitis-vs-NoPancreatitis
4.798200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.551400E-01
Normal-vs-N1
6.537600E-01
N0-vs-N1
9.642300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.104000E-01
Normal-vs-TP53-NonMutant
6.436800E-01
TP53-Mutant-vs-TP53-NonMutant
1.514020E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
